| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 07/13/2005 | EP1414479A4 Peptide for regulation of tissue plasminogen activator |
| 07/13/2005 | EP1001976B1 Peptides having potassium channel opener activity |
| 07/13/2005 | EP0394296B2 Assay of a body fluid for measuring bone resorption |
| 07/13/2005 | CN1639569A Methods and compositions for inducing an immune response |
| 07/13/2005 | CN1639188A Hepta-, octa- and nonapeptides having antiangiogenic activity |
| 07/13/2005 | CN1637416A Fp-ghrelin |
| 07/13/2005 | CN1636589A Non-aqueous polar aprotic peptide formulations |
| 07/13/2005 | CN1210304C Sequence number 3 bioactive peptide |
| 07/13/2005 | CN1210303C Human apolipoprotein polypeptide and its use in resisting vascular proliferation diseases |
| 07/13/2005 | CN1210302C Minor peptide of growth factor receptor KDR of specific combined blood vessel endothelium |
| 07/13/2005 | CN1210301C Bioactive peptide sequential No.18 |
| 07/13/2005 | CN1210300C Bioactive peptide No.29 |
| 07/13/2005 | CN1210299C Sequence No.19 biological active peptide |
| 07/13/2005 | CN1210298C Sequence number 1 bioactive peptide |
| 07/13/2005 | CN1210297C Bioactive peptide sequential No.17 |
| 07/13/2005 | CN1210296C Sequential bioactive peptide No.30 |
| 07/13/2005 | CN1210295C Sequential No.24 bioactive peptide |
| 07/13/2005 | CN1210294C Sequential No.21 bioactive peptide |
| 07/13/2005 | CN1210293C Sequential No.23 bioactive peptide |
| 07/13/2005 | CN1210292C Bioactive peptide sequential No.22 |
| 07/13/2005 | CN1210290C Delivery of nucleic acids |
| 07/12/2005 | US6916904 Inhibition of immune complex formation |
| 07/12/2005 | US6916789 Synthetic polypeptide ligand for use in the treatment of cardiovascular, tumor, viral and hypertensive disorders |
| 07/12/2005 | US6916784 Acyl derivatives of the echinocandin class of cyclic peptide; parasiticide |
| 07/12/2005 | US6916783 Proliferation of chondrocytes to increase the biosynthesis of collagen administering angiotensinogen, angiotensin I and II including analogues, fragments and analogues and type 2 receptor agonists; amino acid sequences; kits |
| 07/12/2005 | US6916631 Comprises monoclonal antibody for diagnosis and treatment of skin disorders |
| 07/12/2005 | US6916607 Gene controlling androgen |
| 07/12/2005 | US6916604 Uses of synthetic peptides corresponding to telopeptide sequences of cross-linked type I collagen metabolites |
| 07/12/2005 | US6916474 Binds immunologically to bacillus anthracis protective antigen with an affinity kd of 140-21 pm determined by surface plasmon resonance |
| 07/09/2005 | CA2452162A1 Diabetogenic epitope from a .alpha./.beta.-gliadin a-ii precursor, .alpha./.beta.-gliadin mm1 precursor or g1b1 |
| 07/07/2005 | WO2005061548A1 Polypeptides for modulating binding of trp channel proteins and trp-associated proteins. |
| 07/07/2005 | WO2005061530A1 Novel proteasome modulators |
| 07/07/2005 | WO2005061529A1 Peptide inhibiting angiontensin converting enzyme |
| 07/07/2005 | WO2005060541A2 Peptides and methods for inducing cellular resistance to infection |
| 07/07/2005 | WO2005040193A3 Synthetic peptides that cause f-actin bundling and block actin depolymerization |
| 07/07/2005 | WO2005032461A3 Novel peptide with osteogenic activity |
| 07/07/2005 | WO2005014798A3 Novel compositions and methods for promoting, inhibiting, and detecting protein entry into cells |
| 07/07/2005 | WO2005014639A3 Periodic antimicrobial peptides |
| 07/07/2005 | WO2005014617A3 Cyclic peptide compositions and methods for treatment of sexual dysfunction |
| 07/07/2005 | WO2004108938B1 Peptide ligands of dendritic cells for nucleic acid vector targeting |
| 07/07/2005 | WO2004108757A3 Antimicrobial polypeptides |
| 07/07/2005 | WO2004031768A3 Method for screening modulators of mitochondrial functioning |
| 07/07/2005 | US20050148515 Peptidomimetics; determining ability to bind growth hormone secretagogue; ghrelin agonists; appetite stimulation; dietetics |
| 07/07/2005 | US20050148513 Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 07/07/2005 | US20050148075 With binding specificity for target nucleotides containing one or GNN triplets; regulating gene expression |
| 07/07/2005 | US20050148030 Using computer generated models to design immunoglobulin specific ligands; immunosuppressants; rational drug design |
| 07/07/2005 | US20050148027 Very large scale immobilized polymer synthesis |
| 07/07/2005 | US20050148002 Sequence of surface immobilized polymers utilizing microfluorescence detection |
| 07/07/2005 | US20050147971 Biomolecule transduction motif mph-1-btm and the use thereof |
| 07/07/2005 | US20050147555 polyvalent targeting ligands that bind to cells used for diagnosis of diseases sensitivity to angiogenesis factor |
| 07/07/2005 | CA2551190A1 Polypeptides for modulating binding of trp channel proteins and trp-associated proteins. |
| 07/07/2005 | CA2550278A1 Novel proteasome modulators |
| 07/06/2005 | EP1549747A2 Metalloprotease activation of myostatin, and methods of modulating myostatin activity |
| 07/06/2005 | EP1549670A1 Template-fixed peptidomimetics with antimicrobial activity |
| 07/06/2005 | EP1549669A1 Tumor targeting agents and uses thereof |
| 07/06/2005 | EP1549668A1 Tumor targeting agents and uses thereof |
| 07/06/2005 | EP1549667A1 Tumor targeting agents and uses thereof |
| 07/06/2005 | EP1549335A1 A method of modulating cellular activity and molecules for use therein |
| 07/06/2005 | EP1549333A1 Compstatin analogs with improved activity |
| 07/06/2005 | EP1268531B1 Method for the production of bacterial toxins |
| 07/06/2005 | EP1071442B1 Methods and compositions for peptide synthesis (t-20) |
| 07/06/2005 | EP0817846B1 Intracellular domain of the her-2/neu protein for prevention or treatment of malignancies |
| 07/06/2005 | CN1636059A Novel method and composition for inhibition of angiogenesis and tumor growth using compounds based on a sequence within MMP-2 |
| 07/06/2005 | CN1636017A Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer |
| 07/06/2005 | CN1636016A Methods to inhibit viral replication |
| 07/06/2005 | CN1635913A A method for treating viral diseases and other disorders by altering immediate gene expression through administration of peptide T |
| 07/06/2005 | CN1634980A Analogues of orphanin FQ |
| 07/06/2005 | CN1634979A Ligand of NKG2D acceptor and use |
| 07/06/2005 | CN1634978A SARS virus HLA-A2 limited epitope polypeptide and uses thereof |
| 07/06/2005 | CN1634595A Tie2 receptor mediated gene transfer system for targeted tumor gene therapy |
| 07/05/2005 | US6914123 Hairpin peptides with a novel structural motif and methods relating thereto |
| 07/05/2005 | US6914122 Macrocyclic NS-3 serine protease inhibitors of hepatitis C virus comprising alkyl and aryl alanine P2 moieties |
| 07/05/2005 | US6914048 Method for delivery of molecules to intracellular targets |
| 07/05/2005 | US6914044 Compounds and methods for modulating cell adhesion |
| 07/05/2005 | CA2298639C Synthetic antineoplastic agents derived from dolastatin 15 and methods of making same |
| 06/30/2005 | WO2005059124A2 Isozyme-specific antagonists of protein kinase c |
| 06/30/2005 | WO2005058959A2 Treatment of viral infections |
| 06/30/2005 | WO2005058943A1 Biphenyl-substituted antibacterial macrocycles |
| 06/30/2005 | WO2005058938A2 Helical synthetic peptides that stimulate cellular cholesterol efflux |
| 06/30/2005 | WO2005058821A1 Inhibitors of hepatitis c virus ns3/ns4a serine protease |
| 06/30/2005 | WO2005023866A3 Peptides that inhibit complement activation |
| 06/30/2005 | WO2004035611A3 Peptides binding the phosphatase 2a protein and polynucleotides encoding same |
| 06/30/2005 | WO2003018611A3 Proaerolysin containing protease activation sequences and methods of use for treatment of prostate cancer |
| 06/30/2005 | US20050143567 Novel gonadotropin-releasing hormone, precursor peptides thereof and genes encoding the same |
| 06/30/2005 | US20050143313 Novel peptide, method of production thereof, and pharmaceutical composition containing the same |
| 06/30/2005 | US20050143312 Compositions and methods for promoting myocardial and peripheral angiogenesis |
| 06/30/2005 | US20050143309 Alkyl peptide amides and applications |
| 06/30/2005 | US20050143302 Inhibiting NF-kappa B-dependent target gene expression in a cell; fusions of a NEMO binding domain and a membrane translocation domain (third helix of antennapedia homeodomain or the HIV-1 Tat protein) |
| 06/30/2005 | US20050143293 Peptides for enhancing resistance to microbial infections |
| 06/30/2005 | US20050143292 Glycopegylated erythropoietin |
| 06/30/2005 | US20050142640 MUC-1 derived peptides |
| 06/30/2005 | US20050142612 Inhibitors of amyloid precursor protein processing |
| 06/30/2005 | US20050142144 Epitope sequences |
| 06/30/2005 | US20050142061 Radiofluorination methods |
| 06/30/2005 | DE10200666A1 New peptide compounds containing upto 6 aminoacid residues, are potent and specific thrombin inhibitors used for treating and diagnosing diseases associated with thrombin |
| 06/30/2005 | CA2549874A1 Antibacterial macrocycles with substituted biphenyl |
| 06/30/2005 | CA2549529A1 Helical synthetic peptides that stimulate cellular cholesterol efflux |
| 06/30/2005 | CA2549167A1 Inhibitors of hepatitis c virus ns3/ns4a serine protease |
| 06/30/2005 | CA2549052A1 Isozyme-specific antagonists of protein kinase c |
| 06/30/2005 | CA2548585A1 Treatment of viral infections |